Best Practices and Research Advances in Thoracic Oncology: A Regional Series Eastern Europe/Baltic Course 2: Immunotherapy in Lung Cancer-A Practical Case to Open Debate

Video Transcription

Video Summary

Dr. Urška Janžić discusses a case of early-stage lung cancer in a 58-year-old male smoker. The patient, diagnosed with stage 3B adenocarcinoma, undergoes neoadjuvant chemotherapy and immunotherapy, resulting in significant tumor shrinkage and complete pathological response post-surgery. Dr. Janžić explores the benefits and questions surrounding perioperative treatment options, including neoadjuvant and adjuvant immunotherapy. Despite uncertain long-term prognosis based on pathological response alone, the patient continues with adjuvant immunotherapy. The case highlights ongoing debate over treatment strategies and the need for extended follow-up data.

Asset Subtitle

Urška Janžič, MD

Keywords

lung cancer

neoadjuvant chemotherapy

immunotherapy

pathological response

treatment strategies